Skip to content Skip to footer

Mikael Maksimow, Ph.D.

Chief Operating Officer

Pekka Simula, M.Sc.

Industry Expert

Consectetur adipiscing elit, sed do euism onsectetur adipiscing elit, sed.

Consectetur adipiscing elit, sed do euism onsectetur adipiscing elit, sed.

Consectetur adipiscing elit, sed do euism onsectetur adipiscing elit, sed.

Harri Sihto, Ph.D.

Chairman of the Board

The Chairman of the Board, Dr. Harri Sihto (born 1976) is a founding member of the Company. He is a biochemist, who received his Ph.D. degree in 2012 and was awarded with title of Adjunct Professor of Cancer Biology in 2015 at the University of Helsinki, Finland. Dr. Sihto’s research group investigates novel therapy targets in sarcomas and other rare cancers to discover new therapeutic options for the patients.

Katja Ivanitskiy, M.D.

Chief Executive Officer

Chief executive officer. Specialist in Public Health, Special Competence in Pharmaceutical Medicine.